Literature DB >> 21208525

Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine.

Diana Couto1, Daniela Ribeiro, Marisa Freitas, Ana Gomes, José L F C Lima, Eduarda Fernandes.   

Abstract

Sulfasalazine is a prodrug composed by a molecule of 5-aminosalicylic acid (5-ASA) and sulfapyridine (SP), linked by an azo bond, which has been shown to be effective in the therapy of inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease, as well as of rheumatic diseases, such as rheumatoid arthritis and ankylosing spondylitis. The precise mechanism of action of sulfasalazine and/or its metabolites has not been completely elucidated, though its antioxidant effects are well established and are probably due to its scavenging effects against reactive oxygen and nitrogen species (ROS and RNS), as well as metal chelating properties, in association to its inhibitory effects over neutrophil oxidative burst. The present work was focused on screening and comparing the potential scavenging activity for an array of ROS (O(2)(•-), H(2)O(2), (1)O(2), ROO(•) and HOCl) and RNS ((•)NO and ONOO(-)), mediated by sulfasalazine and its metabolites 5-ASA and SP, using validated in vitro screening systems. The results showed that both 5-ASA and sulfasalazine were able to scavenge all the tested ROS while SP was practically ineffective in all the assays. For HOCl, (1)O(2), and ROO(•), 5-ASA showed the best scavenging effects. A new and important finding of the present study was the strong scavenging effect of 5-ASA against (1)O(2). 5-ASA was shown to be a strong scavenger of (•)NO and ONOO(-). Sulfasalazine was also able to scavenge these RNS, although with a much lower potency than 5-ASA. SP was unable to scavenge (•)NO in the tested concentrations but was shown to scavenge ONOO(-), with a higher strength when the assay was performed in the presence of 25 mM bicarbonate, suggesting further scavenging of oxidizing carbonate radical. In conclusion, the ROS- and RNS-scavenging effects of sulfasalazine and its metabolites shown in this study may contribute to the anti-inflammatory effects mediated by sulfasalazine through the prevention of the oxidative/nitrative/nitrosative damages caused by these species.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21208525      PMCID: PMC7067340          DOI: 10.1179/135100010X12826446921707

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  46 in total

1.  Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis.

Authors:  H Bantel; C Berg; M Vieth; M Stolte; W Kruis; K Schulze-Osthoff
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

2.  Effects of mesalamine on the hsp72 stress response in rat IEC-18 intestinal epithelial cells.

Authors:  G C Burress; M W Musch; D A Jurivich; J Welk; E B Chang
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

3.  Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity.

Authors:  L J Egan; D C Mays; C J Huntoon; M P Bell; M G Pike; W J Sandborn; J J Lipsky; D J McKean
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

4.  Peroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite-mediated oxidations.

Authors:  A Denicola; B A Freeman; M Trujillo; R Radi
Journal:  Arch Biochem Biophys       Date:  1996-09-01       Impact factor: 4.013

Review 5.  Effects of antirheumatic agents on cytokines.

Authors:  P Barrera; A M Boerbooms; L B van de Putte; J W van der Meer
Journal:  Semin Arthritis Rheum       Date:  1996-02       Impact factor: 5.532

6.  The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species.

Authors:  Eduarda Fernandes; Sofia A Toste; José L F C Lima; Salette Reis
Journal:  Free Radic Biol Med       Date:  2003-11-01       Impact factor: 7.376

7.  Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.

Authors:  T M Neal; C C Winterbourn; M C Vissers
Journal:  Biochem Pharmacol       Date:  1987-09-01       Impact factor: 5.858

8.  Peroxynitrite-induced luminol chemiluminescence.

Authors:  R Radi; T P Cosgrove; J S Beckman; B A Freeman
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

9.  The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?

Authors:  O I Aruoma; M Wasil; B Halliwell; B M Hoey; J Butler
Journal:  Biochem Pharmacol       Date:  1987-11-01       Impact factor: 5.858

Review 10.  Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease.

Authors:  A Prakash; A Markham
Journal:  Drugs       Date:  1999-03       Impact factor: 11.431

View more
  16 in total

Review 1.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

Review 2.  Concepts of oxidative stress and antioxidant defense in Crohn's disease.

Authors:  Mohammed A Alzoghaibi
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

3.  A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug.

Authors:  Mohammad Beiranvand
Journal:  Inflammopharmacology       Date:  2021-08-19       Impact factor: 4.473

4.  Anti-tumor Necrosis Factor Alpha (Infliximab) Attenuates Apoptosis, Oxidative Stress, and Calcium Ion Entry Through Modulation of Cation Channels in Neutrophils of Patients with Ankylosing Spondylitis.

Authors:  Yunus Ugan; Mustafa Nazıroğlu; Mehmet Şahin; Mehmet Aykur
Journal:  J Membr Biol       Date:  2016-03-08       Impact factor: 1.843

5.  A new derivative of acetylsalicylic acid and carnosine: synthesis, physical and chemical properties, biological activity.

Authors:  Olga I Kulikova; Sergey L Stvolinsky; Vasily A Migulin; Ludmila A Andreeva; Igor Yu Nagaev; Olga M Lopacheva; Ksenia N Kulichenkova; Alexander V Lopachev; Irina E Trubitsina; Tatiana N Fedorova
Journal:  Daru       Date:  2020-01-04       Impact factor: 3.117

6.  Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation.

Authors:  Satoshi Yotsumoto; Yuito Muroi; Tatsuya Chiba; Rio Ohmura; Maki Yoneyama; Megumi Magarisawa; Kosuke Dodo; Naoki Terayama; Mikiko Sodeoka; Ryohei Aoyagi; Makoto Arita; Satoko Arakawa; Shigeomi Shimizu; Masato Tanaka
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

7.  Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease.

Authors:  Lichy Han; Mateusz Maciejewski; Christoph Brockel; Lovisa Afzelius; Russ B Altman
Journal:  Inflamm Bowel Dis       Date:  2018-02-15       Impact factor: 5.325

8.  Bacteria induce prolonged PMN survival via a phosphatidylcholine-specific phospholipase C- and protein kinase C-dependent mechanism.

Authors:  Saskia F Erttmann; Nelson O Gekara; Maria Fällman
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  The effect of 5-aminosalicylic acid on renal ischemia-reperfusion injury in rats.

Authors:  Shokofeh Banaei
Journal:  Indian J Pharmacol       Date:  2016 Mar-Apr       Impact factor: 1.200

10.  Identification of PMN-released mutagenic factors in a co-culture model for colitis-associated cancer.

Authors:  Nicolas Granofszky; Michaela Lang; Vineeta Khare; Gerald Schmid; Theresa Scharl; Franziska Ferk; Kristine Jimenez; Siegfried Knasmüller; Christoph Campregher; Christoph Gasche
Journal:  Carcinogenesis       Date:  2018-02-09       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.